-
ETON Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Eton Pharmaceuticals (ETON)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 20.26 mm | 20.26 mm | 20.26 mm | 20.26 mm | 20.26 mm | 20.26 mm |
Cash burn (monthly) | (no burn) | 108.75 k | (no burn) | 240.83 k | (no burn) | 76.00 k |
Cash used (since last report) | n/a | 304.46 k | n/a | 674.24 k | n/a | 212.77 k |
Cash remaining | n/a | 19.96 mm | n/a | 19.59 mm | n/a | 20.05 mm |
Runway (months of cash) | n/a | 183.5 | n/a | 81.3 | n/a | 263.8 |
13F holders | Current |
---|---|
Total holders | 23 |
Opened positions | 8 |
Closed positions | 24 |
Increased positions | 3 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 18.02 bn |
Total shares | 5.48 mm |
Total puts | 1.00 k |
Total calls | 41.00 k |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
Opaleye Management | 2.40 mm | $7.88 bn |
Nantahala Capital Management | 940.73 k | $3.10 bn |
Westside Investment Management | 585.40 k | $1.93 bn |
Paradigm Capital Management | 300.00 k | $987.00 mm |
Bridgeway Capital Management | 253.36 k | $833.56 mm |
Parkman Healthcare Partners | 253.20 k | $833.02 mm |
Aristides Capital | 200.00 k | $658.00 mm |
Susquehanna International | 134.29 k | $441.81 mm |
Stonepine Capital Management | 110.00 k | $361.90 mm |
STT State Street | 81.40 k | $267.82 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Oct 24 | Opaleye Management | Common Stock, par value $0.001 per share | Buy | Acquire P | Yes | No | 7.9814 | 10,000 | 79.81 k | 2,770,000 |
8 Oct 24 | Opaleye Management | Common Stock, par value $0.001 per share | Buy | Acquire P | Yes | No | 7.0292 | 3,970 | 27.91 k | 82,070 |
8 Oct 24 | Opaleye Management | Common Stock, par value $0.001 per share | Buy | Acquire P | Yes | No | 7.0292 | 30,000 | 210.88 k | 2,760,000 |
7 Oct 24 | Opaleye Management | Common Stock, par value $0.001 per share | Buy | Acquire P | Yes | No | 7.2235 | 1,248 | 9.01 k | 78,100 |
7 Oct 24 | Opaleye Management | Common Stock, par value $0.001 per share | Buy | Acquire P | Yes | No | 7.2235 | 10,000 | 72.24 k | 2,730,000 |
4 Oct 24 | Opaleye Management | Common Stock, par value $0.001 per share | Buy | Acquire P | Yes | No | 6.771 | 1,852 | 12.54 k | 76,852 |
4 Oct 24 | Opaleye Management | Common Stock, par value $0.001 per share | Buy | Acquire P | Yes | No | 6.771 | 15,000 | 101.57 k | 2,720,000 |
2 Oct 24 | David Krempa | RSU Common Stock | Grant | Acquire A | No | No | 0 | 42,088 | 0.00 | 861,374 |
11 Sep 24 | Opaleye Management | Common Stock, par value $0.001 per share | Buy | Acquire P | Yes | No | 4.75 | 5,000 | 23.75 k | 75,000 |
11 Sep 24 | Opaleye Management | Common Stock, par value $0.001 per share | Buy | Acquire P | Yes | No | 4.75 | 45,000 | 213.75 k | 2,705,000 |